Search the KHIT Blog

Sunday, April 14, 2013

A new Day. BobbyG's REC campaign is moving to KHIT
I retired from HealthInsight on Friday. They are a great organization. Effusive thanks go out to my REC/HIE colleagues for the fabulous retirement party! (what I remember of it after all those tequila shots they made me chug)

The lengthy work separation from Cheryl has just become beyond untenable. We filed a Nevada General Partnership dba to get things going. The REC blog will soldier on, and will eventually morph into the KHIT blog, as I gradually relocate fully to Walnut Creek.

We will continue to put the microscope on all things Health IT related.

Now up on twitter @KHITradio 

Indeed. That's how I feel now.


No more timesheets for me. It's simple: if I'm not sleeping or doing minimally necessary logistical life stuff (including some overdue exercise), I'm on the job.

Have to follow this case closely.
Human Gene Patentability Case Heads To Supreme Court
  • Oral arguments begin Monday in Myriad Genetics patent suit
  • Legal issues center on whether genes are products of nature
  • Critics say patents hamper scientists, harm patients
  • Myriad says patents reward research, help patients
By Sharon Begley

NEW YORK, April 14 (Reuters) - Soon after learning that his son had autism, Hollywood producer Jon Shestack ("Air Force One") tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder. But his approach to scientists at universities across the country in the late 1990s hit a brick wall: They refused to join forces, much less share the DNA.

"Each thought they needed to hold on to it to publish and patent," Shestack said in an interview. "This seemed criminal to us."
The U.S. Patent and Trademark Office has granted patents on at least 4,000 human genes to companies, universities and others that have discovered and decoded them. Patents now cover some 40 percent of the human genome, according to a scientific study led by Christopher Mason of Weill Cornell Medical College. But if foes of gene patents have their way, that percentage could be rolled back to zero.

On Monday, the U.S. Supreme Court will hear oral arguments in a case that calls into question whether human DNA can be claimed as intellectual property, and remain off limits to everyone without the permission of the patent holder...
See some of my prior posts that touched on "Genomics." I will have to read every word of every amicus brief and the lower court decisions.


I am yet again speechless..

More to come...

No comments:

Post a Comment